Jane Street’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Jane Street’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17,700	Closed	-$109K	–	11288
2021 Q3	$109K	Sell	17,700 -4,600	-21%	-$27.5K	﹤0.01%	9254
2021 Q2	$147K	Sell	22,300 -37,600	-63%	-$259K	﹤0.01%	9061
2021 Q1	$438K	Buy	+59,900	New	+$517K	﹤0.01%	7044

Jane Street's AVEO Position: Q1 2023 in Review

Jane Street sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 80,874 shares — an estimated $1.21M sold.

Jane Street first reported a position in AVEO in Q2 2013 and held it in 13 quarters. The position peaked at $1.21M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Jane Street reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Jane Street sold 80,874 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.21M.
Jane Street first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
Jane Street's AVEO Pharmaceuticals, Inc. position peaked at $1.21M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.